| BCSFX | OSMAX | BCSFX / OSMAX | |
| Total Expense Ratio | 1.06 | 1.42 | 75% |
| Annual Report Gross Expense Ratio | 1.06 | 1.42 | 75% |
| Fund Existence | 11 years | 29 years | - |
| Gain YTD | -17.294 | -1.746 | 990% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 500000 | 1000 | 50,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 752M | 2.34B | 32% |
| Annual Yield % from dividends | 0.90 | 1.41 | 64% |
| Returns for 1 year | -25.77 | -14.98 | 172% |
| Returns for 3 years | -4.90 | -12.96 | 38% |
| Returns for 5 years | -26.48 | -38.76 | 68% |
| Returns for 10 years | 89.04 | 3.24 | 2,745% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBP | 92.74 | 1.10 | +1.20% |
| Virtus LifeSci Biotech Products ETF | |||
| BLSG | 1.99 | -0.01 | -0.37% |
| Leverage Shares 2X Long BLSH Daily ETF | |||
| XOVR | 19.61 | -0.23 | -1.16% |
| ERShares Private-Public Crossover ETF | |||
| FV | 72.43 | -1.55 | -2.10% |
| First Trust Dorsey Wright Focus 5 ETF | |||
| UNG | 11.50 | -0.27 | -2.29% |
| United States Natural Gas | |||